Skip to main content

Table 2 Operative variables and postoperative outcomes of the enrolled patients upon undergoing radical hepatectomy

From: Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Characteristic

Hepatectomy-TACE group (n = 116)

Hepatectomy alone group (n = 118)

P-value

Cirrhosis [cases (%)]

 Present

50 (43.1)

42 (35.6)

0.285

 Absent

66 (56.9)

76 (64.4)

Tumor size [cases (%)]

 5–10 cm

82 (70.7)

97 (82.2)

0.055

 > 10 cm

34 (29.3)

21 (17.8)

Operation time (min)

173.2 ± 48.6

182.3 ± 65.2

0.225

Operation blood loss (mL)

518.9 ± 441.6

421.6 ± 353.3

0.064

Blood transfusion [cases (%)]

26 (22.4)

18 (15.3)

0.183

Extent of liver resection [cases (%)]

 Major

45 (38.8)

46 (39.0)

1.000

 Minor

71 (61.2)

72 (61.0)

Resection margin [cases (%)]

 < 2 cm

91 (78.4)

92 (78.0)

1.000

 ≥ 2 cm

25 (21.6)

26 (22.0)

Postoperative complications [cases (%)]

24 (20.7)

23 (19.5)

0.871

 Grade 1

  Fever

5 (4.3)

3 (2.5)

0.497

 Grade 2

  Fever

2 (1.7)

1 (0.8)

0.620

  Ascites

5 (4.3)

3 (2.5)

0.497

  Transient jaundice

5 (4.3)

6 (5.1)

1.000

  Pleural effusion

3 (2.6)

3 (2.5)

1.000

  Hypoalbuminemia

3 (2.6)

5 (4.2)

0.722

 Grade 3

  Liver bleeding

1 (0.9)

2 (1.7)

1.000

  1. Continuous variables are compared by Student t-test; categorical variables are compared by the χ2 test or the Fisher’s exact test
  2. Hepatectomy-TACE: radical hepatectomy followed by adjuvant transcatheter arterial chemoembolization; Hepatectomy Alone: had undergone only radical hepatectomy